[EN] SMALL MOLECULE C-MYC INHIBITORS<br/>[FR] PETITES MOLÉCULES INHIBITRICES DE C-MYC
申请人:SCRIPPS RESEARCH INST
公开号:WO2015089180A1
公开(公告)日:2015-06-18
This invention provides small molecule Myc-inhibitors. Also provided in the invention are therapeutic applications of these compounds for treating Myc-driven cancer and other related methods.
Synthesis of Furans from Sugars Via Keto Intermediates
申请人:BP Corporation North America Inc.
公开号:US20180057897A1
公开(公告)日:2018-03-01
The present invention provides a method of preparing a furan derivative comprising the steps of (a) converting a monosaccharide to provide a keto-intermediate product; and (b) dehydrating the keto-intermediate product to provide a furan derivative; wherein the keto-intermediate product is pre-disposed to forming keto-furanose tautomers in solution. The method may further comprising a step of oxidizing the furan derivative to provide a furandicarboxylic acid or a furandicarboxylic acid derivative.
[EN] PRODRUG AND PROTECTED FORMS OF 5-HYDROXYMETHYLFURFURANAL (5-HMF) AND ITS DERIVATIVES<br/>[FR] PROMÉDICAMENTS ET FORMES PROTÉGÉES DU 5-HYDROXYMÉTHYLFURFURAL (5-HMF) ET DE SES DÉRIVÉS
申请人:UNIV VIRGINIA COMMONWEALTH
公开号:WO2018018035A1
公开(公告)日:2018-01-25
Prodrugs and derivatives of 5-hydoxymethyl-2-furfural (5-HMF) with protected or modified aldehyde and/or alcohol moieties are provided. The prodrugs or derivatives exhibit increased bioavailability, e.g. due to having extended half-lives in circulation. The drugs are therefore administered i) at lower doses and/or ii) less frequently than 5-HMF, while still maintaining the beneficial therapeutic effects of 5-HMF.
[EN] A PROCESS FOR THE SYNTHESIS OF FURANDICARBOXYLIC ACID<br/>[FR] PROCÉDÉ DE SYNTHÈSE D'ACIDE FURANE DICARBOXYLIQUE
申请人:COUNCIL SCIENT IND RES
公开号:WO2021124354A1
公开(公告)日:2021-06-24
The present invention provides a process for the synthesis of FDC A comprising heating a mixture of fructose, aqueous NaCl or KC1, solvent, methyl isobutyl ketone (MIBK) and a catalyst at a temperature in the range of 150 to 200°C in a sealed vessel for a time period in the range of 2 to 5 hours to yield crude 5-HMF. The crude HMF further reacts with a biocatalyst at a temperature in a range of 20 to 50°C for a period at a range of 24 to 96 hours to yield Furandicarboxylic acid (FDCA) ), wherein the conversion of 5- HMF to FDCA is in the range of 90 to 100%.
[EN] PROCESS FOR THE SYNTHESIS OF 2,5-FURANDICARBOXYLIC ACID.<br/>[FR] PROCÉDÉ DE SYNTHÈSE D'ACIDE 2,5-FURANDICARBOXYLIQUE
申请人:NOVAMONT SPA
公开号:WO2012017052A1
公开(公告)日:2012-02-09
Process for the synthesis of 2,5-furandicarboxylic acid through the oxidation of -hydroxymethylfurfural in a flow of oxygenor a compound containing oxygen, catalysed by a supported catalyst containing a metal of the platinum group, carried out in aqueous solution in which the pH is maintained higher than7 and lower than12through the addition of a weak base.